Evidence map›Paper›PMID 20798941›Full record

ReviewDer Pathologe2010

[Current models of thrombopoiesis].

H Schulze

Open access · bronzeAbstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Der Pathologe, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

H SchulzeLabor für Pädiatrische Molekularbiologie, Klinik für Allgemeine Pädiatrie, Otto-Heubner Centrum für Kinder- und Jugendmedizin, Ziegelstr. 5-9, 10098 Berlin. harald.schulze@charite.de
Klinik und Poliklinik für Kinder- und Jugendmedizin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Platelets are essential corpuscular blood components required for hemostasis. They are released from precursor cells in the bone marrow by cellular fragmentation into the blood stream. Although some aspects of platelet biogenesis are well known, studying its occurrence in vivo has been mostly unsatisfactory. This article reviews some recent findings: It first introduces current models of thrombopoiesis including open questions on cell biology. Second, it presents current findings on the release of megakaryocytes over the endothelial barrier into the blood stream where platelet production takes place outside the bone marrow. Finally, it reports on the translation of the more basic science into an improved understanding of novel parameters from automated blood counters surveying platelet volume (MPV), distribution width (PDW), mass (PCT) and the immature platelet fraction (IPF) into clinics where platelet counts are often the only accessible parameter to evaluate the risk of bleeding. Combining the comprehension of these parameters with a more refined image of how and where platelets are born might help find the cause and best therapy when platelet counts are low.

Indexed as

Blood PlateletsBone Marrow CellsCell BiologyCell SizeEndothelium, VascularHemostasisHumansMegakaryocytesPlatelet CountThrombopoiesis

Identifiers

PMID20798941
OpenAlexW2149224021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.